BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 26, 2025
See today's BioWorld MedTech
Home
» Shiratronics reduces risk for antimigraine neurostimulator implant
To read the full story,
subscribe
or
sign in
.
Patents
Shiratronics reduces risk for antimigraine neurostimulator implant
March 4, 2024
By
Simon Kerton
Shiratronics Inc. seeks patent protection for a rechargeable subcutaneous neurostimulator implant and a method for managing heat during recharge of its battery from an external device and headset.
BioWorld MedTech
U.S.
Patents